StockNews.AI
AWH
StockNews.AI
161 days

Aspira Women's Health Announces Closing of $1.37 Million Private Placement of Convertible Notes

1. Aspira Women's Health raised $1.37 million through convertible promissory notes. 2. The notes are due in 2030, improving financial stability.

2m saved
Insight
Article

FAQ

Why Bullish?

The secured funding supports Aspira's operations, reminiscent of past fundraising boosting investor confidence.

How important is it?

The funding enhances liquidity and operational capacity, crucial for market confidence.

Why Short Term?

Immediate financing can lead to positive operational outcomes within the next fiscal period.

Related Companies

AWHMDVLCRHM
AUSTIN, TX / ACCESS Newswire / March 11, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that it has entered into a securities purchase agreement dated March 6, 2025, pursuant to which the Company has sold and issued an aggregate principal amount of $1.37 million in the form of Senior Secured Convertible Promissory Notes due March 6, 2030 (the "Convertible Notes") in a private placement (the "Private Placement") with existing and new accredited investors. The Convertible Notes will be a senior, secured obligation of the Company and interest will accrue and be payable quarterly in kind at the applicable federal rate (currently 3.34%).

Related News